Evidence map›Paper›PMID 42037189›Full record

Trial reportPain research & management2026

Oliceridine for Analgesia in Elderly Patients Undergoing Kyphoplasty: From a Clinical Trial.

Chenfang Miao, Digui Weng, Chengzhao Liu, Qingqing Huang, Kongning Chen, Bin Zou

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Pain research & management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenfang MiaoDepartment of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.ORCID https://orcid.org/0009-0004-5353-9269
Digui WengDepartment of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.
Chengzhao LiuDepartment of Orthopaedics, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.ORCID https://orcid.org/0009-0000-2685-1215
Qingqing HuangDepartment of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.ORCID https://orcid.org/0009-0007-5067-9065
Kongning ChenDepartment of Orthopaedics, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.
Bin ZouDepartment of Orthopaedics, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.ORCID https://orcid.org/0000-0002-3242-9130

Funding

Fujian Medical University 2024QH1258
6 · The paper itself

Abstract

backgroundAs a G protein-biased μ-opioid receptor agonist, oliceridine can offer a relatively effective and safe analgesia. However, its effect on patients suffering from kyphoplasty was unexplored.

aimThis study was aimed to determine the median effective dose (ED

methodsThis prospective study included a total of 105 elderly patients with osteoporotic vertebral compression fractures (OVCFs) who underwent elective percutaneous kyphoplasty (PKP). The included subjects were divided into young age group (65-74 years old), middle age group (75-84 years old), and old age group (≥ 85 years old). The ED

resultsWhen combined with remimazolam, the ED

conclusionThe ED

trial registrationChinese Clinical Trial Register: ChiCTR2400095085.

Indexed as

AnalgesiaAnalgesicsKyphoplastyAgedAged, 80 and overAge FactorsDose-Response Relationship, DrugFemaleFractures, CompressionHumansMaleMiddle AgedPain MeasurementProspective StudiesSpinal FracturesAnalgesicsageanalgesiadose-response relationshipoliceridinepercutaneous kyphoplastysequential method

Identifiers

PMID42037189
PMCPMC13111982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.